This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Intellectual Property

Mar. 13, 2014

Ambry Genetics beats back injunction in Myriad genetic test case

Aliso Viejo-based Ambry Genetics Corp. warded off a preliminary injunction push from Myriad Genetics Inc., causing an 8 percent drop in the Utah-based genetic test seller's shares during trading Tuesday.

By Kevin Lee
Daily Journal Staff Writer

Aliso Viejo-based Ambry Genetics Corp. warded off a preliminary injunction push from Myriad Genetics Inc., causing an 8 percent drop in the Utah-based genetic test seller's shares during trading Tuesday.

Myriad was trying to bar the sale of Ambry products that allegedly infringe its breast and ovarian cancer testing patents. The company claimed it was losing potential customers from Ambry's products, but U.S. District Judge Ro...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up